Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report
Whereas the interaction between clozapine and ciprofloxacin is well-documented, this case report emphasizes the importance of closely monitoring clozapine plasma concentrations during concurrent administration. When available, clozapine concentrations may be obtained via immunoassay to assess clozap...
Saved in:
| Main Authors: | Kristin Waters, PharmD, BCPS, BCPP, Victoria Popielarz, BS, PharmD Candidate, Joseph Lumasag, BS, PharmD Candidate, Sara Wiesenfeld, BS, PharmD Candidate, Ashley Tewksbury, PharmD, BCPP |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association of Psychiatric Pharmacists
2025-06-01
|
| Series: | Mental Health Clinician |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.06.191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clozapine plasma level toxicity induced by a pharmacokinetic interaction with bupropion: A case report
by: Kelly N. Gable, PharmD, BCPP, et al.
Published: (2025-06-01) -
Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
by: Maxwell Lamb, PharmD, BCPS, et al.
Published: (2025-06-01) -
Management of antidepressant-induced bruxism
by: Hayley Cliatt, PharmD, et al.
Published: (2025-06-01) -
Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01) -
Evaluation of burnout among Board-Certified Psychiatric Pharmacists in the United States
by: Samantha Catanzano, PharmD, BCPP, et al.
Published: (2025-06-01)